Current Hypertension Reports

, 21:66 | Cite as

Anxiety and Hypertension: Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension

  • Heather M. JohnsonEmail author
Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Secondary Hypertension: Nervous System Mechanisms


Purpose of Review

To review the most recent literature on the association between comorbid anxiety disorders and hypertension.

Recent Findings

Recent longitudinal and cross-sectional studies across geographic regions and age groups predominantly demonstrate a positive association between comorbid anxiety and prevalent or incident hypertension. Growing research on blood pressure variability and reduced baroreflex sensitivity in response to autonomic dysfunction provides a greater understanding of mechanistic relationships between anxiety and hypertension. Observational studies demonstrate that young adults are at a higher risk for developing incident hypertension after an anxiety diagnosis, supporting longer exposure to alterations in autonomic mechanisms. Confounding relationships of comorbid anxiety with depression likely contribute to prior conflicting results on the association between anxiety and hypertension.


There is increasing evidence of a positive association between comorbid anxiety and hypertension. This contemporaneous review supports similar findings in historical studies and provides mechanistic hypotheses for larger, longitudinal studies.


Hypertension Anxiety disorder Health behavior Autonomic nervous system Comorbidity Risk factors 


Compliance with Ethical Standards

Conflict of Interest

The author declares no conflicts of interest relevant to this manuscript. Dr. Johnson reports grants from NIH/NHLBI, outside the submitted work.

Human and Animal Rights

All reported studies/experiments with human or animal subjects performed by the author have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134:441–50. Scholar
  2. 2.
    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2010;380:2224–60. Scholar
  3. 3.
    World Health Organization. Global Health Observatory (GHO) data. Raised blood pressure – situation and trends. Website: May 31, 2019.
  4. 4.
    Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al., on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2019 update: a report from the American Heart Association [published online ahead of print January 31, 2019]. Circulation.
  5. 5.
    Bacon SL, Campbell TS, André A, Lavoie KL. The impact of mood and anxiety disorders on incident hypertension at one year. Int J Hypertens. 2014;2014(953094):7. Scholar
  6. 6.
  7. 7.
    Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17:3.Google Scholar
  8. 8.
    Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization 2017. License: CC BY-NC-SA 3.0 IGO. Website:;jsessionid=3C066D350D7C8E8630F9F3DF6844E976?sequence=1. Accessed June 28, 2019.
  9. 9.
    O’Donovan A, Slavich GM, Epel ES, Neylan TC. Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev. 2013;37:96–108.CrossRefGoogle Scholar
  10. 10.
    Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry. 1996;53(10):889–95.CrossRefGoogle Scholar
  11. 11.
    •• Wallace K, Zhao X, Misra R, Sambamoorthi U. The humanistic and economic burden associated with anxiety and depression among adults with comorbid diabetes and hypertension. J Diabetes Res. 2018;2018(4842520):9. eCollection 2018. This analysis of data from the 2013 and 2015 United States Medical Expenditure Panel Survey evaluated the health-related quality of life (HRQoL) and economic burden on the presence of anxiety among patients with hypertension and other comorbidities. This study highlights the need for cost-effective, collaborative care for patients with comorbid conditions. CrossRefGoogle Scholar
  12. 12.
    Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med. 2002;64(5):758–66.PubMedGoogle Scholar
  13. 13.
    Hildrum B, Mykletun A, Holmen J, Dahl A. Effect of anxiety and depression on blood pressure: 11-year longitudinal population study. Br J Psychiatry. 2008;193(2):108–13. Scholar
  14. 14.
    Wu EL, Chien IC, Lin CH. Increased risk of hypertension in patients with anxiety disorders: a population-based study. J Psychosom Res. 2014;77:522–7.CrossRefGoogle Scholar
  15. 15.
    Cuffee Y, Ogedegbe C, Williams NJ, Ogedegbe G, Schoenthaler A. Psychosocial risk factors for hypertension: an update of the literature. Curr Hypertens Rep. 2014;16(10):483. Scholar
  16. 16.
    Kaliyaperumal S, Hari SB, Siddela PK, Yadala S. Assessment of quality of life in hypertensive patients. J Appl Pharm Sci. 2016;6(05):143–7.CrossRefGoogle Scholar
  17. 17.
    Saboya PM, Zimmermann PR, Bodanese LC. Association between anxiety or depressive symptoms and arterial hypertension, and their impact on the quality of life. Int J Psychiatry Med. 2010;40(3):307–20.CrossRefGoogle Scholar
  18. 18.
    Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med. 1997;6:43–9.CrossRefGoogle Scholar
  19. 19.
    Player MS, Peterson LE. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med. 2011;41(4):365–77.CrossRefGoogle Scholar
  20. 20.
    Bhat SK, Beilin LJ, Robinson M, Burrows S, Mori TA. Relationships between depression and anxiety symptoms scores and blood pressure in young adults. J Hypertens. 2017;35:1983–91.CrossRefGoogle Scholar
  21. 21.
    Markovitz JH, Matthews KA, Wing RR, Kuller LH, Meilahn EN. Psychological, biological and health behavior predictors of blood pressure changes in middle-aged women. J Hypertens. 1991;9:399–406.CrossRefGoogle Scholar
  22. 22.
    Perez-Pinar M, Mathur R, Foguet Q, Ayis S, Robson J, Ayerbe L. Cardiovascular risk factors among patients with schizophrenia, bipolar, depression, anxiety, and personality disorders. European Psychiatry. 2016;35:8–15.CrossRefGoogle Scholar
  23. 23.
    Jonas BS, Lando JF. Negative affect as a prospective risk factor for hypertension. Psychosom Med. 2000;62:188–96.CrossRefGoogle Scholar
  24. 24.
    László A, Tabák A, Kőrösi B, Eörsi D, Torzsa P, Cseprekál O, et al. Association of affective temperaments with blood pressure and arterial stiffness in hypertensive patients: a cross-sectional study. BMC Cardiovasc Disord. 2016;16:158. Scholar
  25. 25.
    Cheung BM, Au T, Chan S, Lam C, Lau S, Lee R, et al. The relationship between hypertension and anxiety or depression in Hong Kong Chinese. Exp Clin Cardiol. 2005;10:21–4.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Johannessen L, Strudsholm U, Foldager L, Munk-Jørgenson P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006;95(1–3):13–7.CrossRefGoogle Scholar
  27. 27.
    Egan BM, Zhao Y. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013;15(3):154–61. Scholar
  28. 28.
    Johnson HM, Thorpe CT, Bartels CM, Schumacher JR, Palta M, Pandhi N, et al. Undiagnosed hypertension among young adults with regular primary care use. J Hypertens. 2014;32(1):65–74. Scholar
  29. 29.
    Delaney JA, Oddson BE, Kramer H, Shea S, Psaty BM, McClelland RL. Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the multi-ethnic study of atherosclerosis. Hypertension. 2010;55(2):408–14. Scholar
  30. 30.
    Stein DJ, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, de Jonge P, Miguel Caldas-de-Almeida J, et al. Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry. 2014;36(2):142–9. Scholar
  31. 31.
    Jarman B, Townsend P, Carstairs V. Deprivation indices. BMJ. 1991;303(6801):523.CrossRefGoogle Scholar
  32. 32.
    Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403–39.CrossRefGoogle Scholar
  33. 33.
    Jackson JA, Pathirana T, Gardiner PA. Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study. J Hypertens. 2016;34:1959–66.CrossRefGoogle Scholar
  34. 34.
    Low M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H. Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study). Dtsch Med Wochenschr. 2004;129:2643–7.CrossRefGoogle Scholar
  35. 35.
    Matouk I, Herzog W, Bohlen F, Quinzler R, Lowe B, Saum KU, et al. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. J Hypertens. 2016 Sep;34(9):1711–20. Scholar
  36. 36.
    Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens. 2012;30(5):842–51. Scholar
  37. 37.
    Carroll D, Phillips AC, Gale CR, Batty GD. Generalized anxiety and major depressive disorders, their comorbidity and hypertension in middle-aged men. Psychosom Med. 2010;72(1):16–9.CrossRefGoogle Scholar
  38. 38.
    Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, et al. Depression–anxiety relationships with chronic physical conditions: results from the World Mental Health surveys. J Affect Disord. 2007;103(1–3):113–20.CrossRefGoogle Scholar
  39. 39.
    • Sandstrom YK, Ljunggren G, Wandell P, Wahlstrom L, Carlsson AC. Psychiatric comorbidities in patients with hypertension – a study of registered diagnoses 2009–2013 in the total population in Stockholm County, Sweden. J Hypertens. 2016;34:414–20 Analysis of this observational cohort of over 2 million adults in Sweden demonstrated significantly higher rates of hypertension among men and women with anxiety, after adjusting for age, sociodemographic factors, and health behavior. CrossRefGoogle Scholar
  40. 40.
    Niles AN, Dour HJ, Stanton AL, Roy-Byrne PP, Stein MB, Sullivan G, et al. Anxiety and depressive symptoms and medical illness among adults with anxiety disorders. J Psychosom Res. 2015;78(2):109–15. Scholar
  41. 41.
    Seldenrijk A, Vogelzangs N, Batelaan NM, Wieman I, et al. Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res. 2015;78(2):123–9.CrossRefGoogle Scholar
  42. 42.
    Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med. 2000;160(13):1913–21. Scholar
  43. 43.
    •• Tully PJ, Tzourio C. Psychiatric correlates of blood pressure variability in the elderly: The Three City cohort study. Physiol Behav. 2017;168:91–87. This prospective analysis of over 1400 elderly participants demonstrated that generalized anxiety disorder is significantly associated with increased systolic blood pressure variability over 8 years of follow-up, contributing mechanistic pathophysiology data between comorbid anxiety and hypertension. CrossRefPubMedGoogle Scholar
  44. 44.
    Irigoyen MC, De Angelis K, dos Santos F, Dartora DR, Rodrigues B, Consolim-Colomdo FM. Hypertension, blood pressure variability, and target organ lesion. Curr Hypertens Rep. 2016;18:31. Scholar
  45. 45.
    Piccirillo G, Elvira S, Bucca C, Viola E, Cacciafesta M, Marigliano V. Abnormal passive head-up tilt test in subjects with symptoms of anxiety power spectral analysis study of heart rate and blood pressure. Int J Cardiol. 1997;60(2):121–31.CrossRefGoogle Scholar
  46. 46.
    Virtanen R, Jula A, Salminen J, Voipio-Pulkki LM, Helenius H, Kuusela T, et al. Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-to-beat blood pressure variability. Psychosom Med. 2003;65(5):751–6.CrossRefGoogle Scholar
  47. 47.
    Strine TW, Mokdad AH, Dube SR, Balluz LS, Gonzalez O, Berry JT, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry. 2008;30(2):127–37. Scholar
  48. 48.
    Grimm ER, Steinle NI. Genetics of eating behavior: established and emerging concepts. Nutr Rev. 2011;69:52–60. Scholar
  49. 49.
    Mensorio MS, Cebolla A, Lison JF, Rodilla E, Palomar G, Miragall M, et al. Emotional eating as a mediator between anxiety and cholesterol in population with overweight and hypertension. Psychol Health Med. 2017;22(8):911–8. Scholar
  50. 50.
    van Strien T, Frijters JER, Bergers GPA, Defares PB. The Dutch eating behavior questionnaire (DEBQ) for assessment of restrained, emotional, and external eating behavior. Int J Eat Disord. 1986;5:295–315.CrossRefGoogle Scholar
  51. 51.
    van Strien T, Cebolla A, Etchemendy E, Gutierrez-Maldonado J, Ferrer-Garcia M, Botella C, et al. Emotional eating and food intake after sadness and joy. Appetite. 2013;66:20–5. Scholar
  52. 52.
    van Strien T, Konttinen H, Homberg JR, Engels RCME, Winkens LHH. Emotional eating as a mediator between depression and weight gain. Appetite. 2016;100:216–24. Scholar
  53. 53.
    Goossens L, Braet C, Van Vlierberghe L, Mels S. Loss of control over eating in overweight youngsters: the role of anxiety, depression and emotional eating. Eur Eat Disord Rev. 2009;17:68–78.CrossRefGoogle Scholar
  54. 54.
    Assari S. Additive effects of anxiety and depression on body mass index among blacks: role of ethnicity and gender. Int Cardiovasc Res J. 2014;8(2):44–51.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Lykouras L. Psychological profile of obese patients. Dig Dis. 2008;26:36–9. Scholar
  56. 56.
    Ho AK, Thorpe CT, Pandhi N, Palta M, Smith MA, Johnson HM. Association of anxiety and depression with hypertension control: a US multidisciplinary group practice observational study. J Hypertens. 2015;33(11):2215–22. Scholar
  57. 57.
    Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Heal Syst. 2014;8:25. Scholar
  58. 58.
    Sullivan G, Craske MG, Sherbourne C, Edlund MJ, Rose RD, et al. Design of the coordinated anxiety learning and management (CALM) study: innovations in collaborative care for anxiety disorders. Gen Hosp Psychiatry. 2007;29(5):379–87.CrossRefGoogle Scholar
  59. 59.
    Istenes I, Körei AE, Putz Z, Németh N, Martos T, Keresztes K, et al. Heart rate variability is severely impaired among type 2 diabetic patients with hypertension. Diabetes Metab Res Rev. 2014;30(4):305–12.CrossRefGoogle Scholar
  60. 60.
    Mermerelis A, Kyvelou SM, Akke V, Papageorgiou C, Stefanadis C, Douzenis A. EV0029. Is there a difference in prevalence of anxiety and depression symptoms among patients with different stages of hypertension? Abstract. 25th European Congress of Psychiatry/European Psychiatry 41S 2017:S405–S464.Google Scholar
  61. 61.
    Pan Y, Cai W, Cheng Q, Dong W, An T, Yan J. Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat. 2015;11:1121–30. Scholar
  62. 62.
    Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. 2015;28(11):1295–302. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Medicine, Division of Cardiovascular MedicineUniversity of Wisconsin School of Medicine & Public HealthMadisonUSA

Personalised recommendations